Comoros vs El Salvador: Access to anti-retroviral drugs, female
Comoros
74.0%
in 2024
El Salvador
74.0%
in 2024
Comoros rank
69th
El Salvador rank
69th
Access to anti-retroviral drugs, female over time
- Comoros
- El Salvador
How they compare
Comoros currently reports 74.0% against 74.0% in El Salvador, a difference of 0.0%.
Across all 25 years both countries report, El Salvador has been ahead every year.
Comoros ranks 69th and El Salvador ranks 69th of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Comoros | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 11.9% | 11.9% | El Salvador |
| 2010s | 42.4% | 64.3% | 21.9% | El Salvador |
| 2020s | 70.2% | 74.2% | 4.0% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Comoros or El Salvador?
- Comoros, at 74.0% against 74.0% in El Salvador as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Comoros and El Salvador?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and El Salvador?
- 25 years are reported by both, from 2000 to 2024.
- How do Comoros and El Salvador rank globally for access to anti-retroviral drugs, female?
- Comoros ranks 69th and El Salvador ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.